Hydroxyurea for the treatment of sickle cell disease

Acta Haematologica

Volumn 88, Issue 4, 1992, Pages 170-174

  El Hazini, Mohsen A F ^a   Warsy, Arjumand S ^b   Al Momen, Abdulkarim ^a   Harakati, Mohamed ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Hb S thalassaemia; Hydroxyurea; Saudi Arabia; Sickle cell anaemia

Indexed keywords

BILIRUBIN; BILIRUBIN GLUCURONIDE; HEMOGLOBIN F; HYDROXYUREA;

ADOLESCENT; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CELL VOLUME; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; DRUG EFFICACY; ERYTHROCYTE COUNT; ERYTHROCYTE DEFORMABILITY; FEMALE; FOLLOW UP; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETICULOCYTE COUNT; SICKLE CELL; SICKLE CELL ANEMIA; THROMBOCYTE COUNT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; DRUG EVALUATION; FEMALE; HUMAN; HYDROXYUREA; MALE; SAUDI ARABIA; SEVERITY OF ILLNESS INDEX; SUPPORT, NON-U.S. GOV'T;

EID: 0027078308     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000204681     Document Type: Article

References (24)

1. Edelstein, S.J.; Molecular topology in crystals anil fibers of haemoglobin S. J Med Biol 1981; 150:557-575.
2. Pacllan, E.A., Love, W.E.; Refined crystal structure of deoxyhaemoglobins. II. Molecular interactions in the crystal. J Biol Chcm 1985: 260:8280-8291.
3. Embury, S.H.; The clinical pathophysiology of sickle cell disease. Annu Rev Med 1986:37:361-376.
4. Brewer, G.J.; Detours on the road to successful treatment of sickle cell anaemia. Perspect Biol Med 1979:22:250-272.
5. Rosa, J., Bengard, J., Hercules, J., (eds); Development of Therapeutic Agents for Sickle Cell Disease. New York. Elsevier/North Holland Biomedical Press. 1979.
6. Warsy, A.S., El-Hazmi, M.A.F., Bahakim, M.M.; Molecular therapy of sickle cell anaemia - The state of art. Saudi Med J 1985:6:257-263.
7. Piatt, O.S., Orkin, S.H., Dover, G., Beardsley, G.P., Miller, B., Nathan, D.G.; Hydroxyurea enhances fetal hemoglobin production in sickle cell anaemia. J Clin Invest 1984;74:652-656.
8. Charache, S., Dover, G.J., Moyer, M.A., Moore, J.W.; Hydroxy-urea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia. Blood 1987:69:109-116.
9. Goldberg, M.A., Brugnara, C., Dover, G.J., Scha-pira, L., Charache, S., Bunn, F.; Treatment of sickle cell anaemia with hydroxyurea and erythropoietin. N Engl J Med 1990;323:366-372.
10. Dover, G.J., Humphries, R.K., Moore, J.G.; Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F-cell production. Blood 1986: 67:735-738.
11. Rodgers, G.P., Dover, G.J., Noguchi, C.T., Schechter, A.N., Nienhuis, A.W.; Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea. N Engl J Med 1990;322: 1037-1045.
12. El-Hazmi, M.A.F., Warsy, A.S.; On the nature of sickle cell disease in the Southwestern Province of Saudi Arabia. Acta Haematol (Basel) 1986; 76:212-216.
13. Fabricius, E., Rajewsky, M.F.; Determination of hydroxyurea in mammalian tissues and blood. Rev Eur Eludes Clin Biol 1971:16:679-683.
14. Robinson, A.R., Robson, M., Harrison, A.P., Zcul-zer, W.W.; A new technique for differentiation of haemoglobin. J Lab Clin Med 1957:50:745-752.
15. Marengo-Rowe, A.J.; Rapid electrophoresis and quantitation of haemoglobins on cellulose acetate. J Clin Pathol 1965:18:790-792.
16. El-Hazmi, M.A.F., Lehmann, H.; Interaction between iron deficiency and d-thalassaemia: The in vitro effect of haemin on a-chain synthesis. Acta Haematol (Basel) 1978:60:1-9.
17. Betke, K., Marti, H.R., Schlicht, I.; Estimation of small percentage of foetal haemoglobin. Nature 1959;184:1877-1878.
18. Kits for Hb F distribution from Boehringer-Miinnhcim GmbH Diagnostic (Test-Combination Fetal Hemoglobin. Cat. No. 124249).
19. Reid, H.C., Barns, A.J., Lock, P.J., Dormandy, J.A., Dormandy, T.L.A.; Simple method for measuring erythrocyte deformability. J Clin Pathol 1976: 29:855-858.
20. El-Hazmi, M.A.F.; Iieta-globin gene haplotypes in Saudi sickle cell anaemia patients. Hum Hered 1990;40:177-186.
21. El-Hazmi, M.A.F.; a-Thalassaemia in Saudi Arabia: Deletion pattern. Hum Genet 1987:76:196-198.
22. El-Hazmi, M.A.F.; Xmn I polymorphism in the gamma-globin gene region among Saudis. Hum Hered 1989:39:12-19.
23. El-Hazmi, M.A.F.; β-Globin gene polymorphism in the Saudi Arab population. Hum Genet 1986:73:31-34.
24. El-Hazmi, M.A.F., Bahakim, H.M., Babikar, M.A., Al-Swailem, A.M., Warsy, A.S.; Symptom-free intervals in sicklers - Docs pneumococcal vaccination and penicillin prophylaxis have a role? J Trop Pediatr 1990:36:56-62.